Keywords: Hypoxia; Gene expression; Mouse blastocyst; Mmp-9; uPA; Pluripotency;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BIA; Building-Integrated Agriculture; CEA; Controlled-Environment Agriculture; GHG; Greenhouse gas; GWP; Global Warming Potential; PF; Plant Factory; RF; Rooftop farming; RG, RTG; Rooftop greenhouse; SC; Shipping Container; UPA; Urban and periurban agricu
Keywords: IFN; interferon; TMA; thrombotic microangiopathy; HUVECs; human umbilical vein endothelial cells; IFNAR; IFN-α/β receptor; JAKs; Janus kinases; STAT; signal transducer and activator of transcription; mAb; monoclonal antibody; VEGF; vascular endothelial
Keywords: Carcinogenesis; Chemoprevention; Chemotherapy; Oxidative stress; Nrf2; Phytochemicals; AKT; protein kinase B; AMPK; AMP-activated protein kinase; ARE; antioxidant response element; ATF-2; activating transcriptional factor; BBN; N-butyl-N-(4-hydroxybutyl)n
Keywords: uPA; uPAR; PAI-1; Invasion; EMT; Metastasis;
Keywords: Eosinophilic esophagitis; eosinophilic oesophagitis; esophageal epithelium; epithelial differentiation; epithelial barrier; proteases; protease inhibitors; serine protease inhibitors; Kazal type; AD; Atopic dermatitis; ALI; Air-liquid interface; BMP; Bone
Keywords: 4- Shogaol (PubChem CID: 9794897); 6- Shogaol (PubChem CID: 5281794); Apigenin (PubChem CID: 5280443); Berberine (PubChem CID: 2353); Bergamottin (PubChem CID: 5471349); Caffeic acid (PubChem CID: 689043)Capsaicin (PubChem CID: 1548943); Cardamonin (PubCh
Keywords: Nanomedicine; Nanodiagnostics; Liquid biopsy; Biophotonics; Pancreatic cancer detection; Pancreatic ductal adenocarcinoma; Sub-femtomolar limit of detection; AJCC; American Joint Commission on Cancer; MMP; matrix metalloproteinase; CTS; cathepsin; UpA; ur
Keywords: A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
Keywords: 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: uPA; urokinase plasminogen activator; PAI-1; plasminogen activator inhibitor 1; ctDNA; circulating tumor DNA; CTC; circulating tumor cells; PFS; progression-free survival; pCR; pathological complete response; SNVs; single nucleotide variants; CNVs; copy n
Keywords: ADAMs; a disintegrin and metalloproteinases; ADAMTS; ADAMs with thrombospondin motifs; Col; collagen; CS; chondroitin sulfate; CTGF; connective tissue growth factor; DS; dermatan sulfate; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epith
Keywords: Shoreline evolution; Users' perception; Carrying capacity; Overcrowding; Beach management; Emilia-Romagna; LC; Lidi di Comacchio; LV; Lido di Volano; LN; Lido di Nazioni; LP; Lido di Pomposa; LS; Lido degli Scacchi; PG; Porto Garibaldi; MM; Milano Maritti
Keywords: BVs; blood vessels; CSF; cerebrospinal fluid; ECM; extracellular matrix; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; GFAP; glial fibrillary acidic protein; IF; immunofluorescence; LV; lateral ventricle; MRI; magnetic resonance imaging; PBS; phosphate
Keywords: â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: Enzyme catalysis; Cyclic peptide; Protease inhibitor; Substrate; Crystal structure; uPA; urokinase-type plasminogen activator serine protease domain of uPA (residues 16-244); uPA16-244; equilibrium dissociation constant; KD; equilibrium inhibition con
Keywords: RNCGDQLZIATDOU-ZDRBWGSPSA-N; ICYPJNZJUFGALC-PDTBJYIYSA-N; PDRMAVOIWIVXKH-SFUSBHMVSA-N; ISADXJRTBSLWPX-ZDRBWGSPSA-N; NLBLLPROASDPSC-QWWZWVQMSA-N; XKMIKZDBUOHHDK-ZDRBWGSPSA-N; BTURADNXKHTWGA-IJOLSIAMSA-N; UEKHRDLXBMZMPD-ZYIYBEKCSA-N; UQCLCXDOXVZEOA-JARUQAPT
Keywords: BMI; body mass index; EC; emergency contraception; IUD; intrauterine device; LARC; long-acting reversible contraceptive; LNG; levonorgestrel; OR; odds ratio; UPA; ulipristal acetate;
Keywords: uPA; urokinase-type plasminogen activator; uPA16-244; serine protease domain of uPA (residues 16-244); KD; equilibrium dissociation constant; Ki; equilibrium inhibition constant; PAB; p-aminobenzamidine; Serine proteases; uPA; Enzyme catalysis; Cyclic
Keywords: endogenous lysis; plasminogen activator inhibitor; streptokinase; synergy; tissue plasminogen activator; urokinase-type plasminogen activator; AMI; acute myocardial infarction; ICH; intracranial hemorrhage; PCI; percutaneous coronary intervention; pro-uPA
Keywords: WHO; World Health Organization; TNF; tumor necrosis factor; IL; interleukin; HSC; hematopoietic stem cell; NSG; NOD/SCID/γcâ/â; NK; natural killer; DC; dendritic cell; TCR; T cell receptor; DTH; delayed type hypersensitivity; HLA; human leukocyte ant
Keywords: POAG; tPA; uPA; LRP-1; RAP; tPA-Stop; Degeneration of RGCs; POAG; Primary Open-Angle Glaucoma; IOP; intraocular pressure; tPA; tissue plasminogen activator; uPA; urokinase plasminogen activator; LRP-1; low density lipoprotein-related receptor-1; RAP; rece
Keywords: Kallikrein-related peptidase; KLK; Cancer; Function; Protease; Carcinogenesis; AR; androgen receptor; B2R; kinin receptor B2; BMP; bone morphogenic protein; CDH; cadherin; DHT; dihydrotestosterone; DNA; deoxyribonucleic Acid; Dsg; desmoglein; ECM; extrace
Keywords: ACPP; activated cell-penetrating peptide; AFM; atomic force microscopy; AN; angiopeptin; ANP; NP modified with ACPP peptide; APE-1; apurinic endonuclease-1; AU; gold; AUC; area under the curve; AUNP; gold nanoparticles; AUNS; gold nanoshells; BAT; brain a
Keywords: Protease; Live-cell imaging; Breast cancer; Tumor microenvironment; 3D models; ABPs; activity-based probes; CAFs; carcinoma-associated fibroblasts; DCIS; ductal carcinoma in situ; DQ; dye quenched; ECM; extracellular matrix; FRET; fluorescence resonance e
Keywords: uPA; urokinase-type plasminogen activator, urokinase; uPAR; urokinase receptor; DRG; Dorsal Root Ganglia; Urokinase; Urokinase receptor; 3D explants of Dorsal Root Ganglia (DRG); Axon growth; Axon branching; Neuronal migration;
Keywords: urinary bladder; ureterocele; congenital abnormalities; lower urinary tract symptoms; urinary tract infections; CIC; clean intermittent catheterization; DSU; duplex system ureterocele; DVSS; Dysfunctional Voiding Scoring System; EI; endoscopic incision; E
Keywords: uPA; urokinase-type plasminogen activator; uPAR; uPA receptor, all forms; uPAR(I-III); intact uPAR; uPAR(I); uPAR domain I; uPAR(II-III); cleaved uPAR domains II-III; TR-FIA; time-resolved fluorescence immunoassay; CRC; colorectal cancer; CV; coeffi
Keywords: uPA; Soluble uPAR; Migration; Cell signaling; Human coronary smooth muscle cell
Keywords: Peptide therapeutics; Intracellular PPI; Undruggable targets; Peptide drugs; Stapling; Hydrogen bond surrogates; Beta-hairpin mimetics; Molecular grafting; Macrocyclization; PPI; protein-protein interaction; HTS; high-throughput screening; PK; pharmacok
Keywords: ARNT; aryl hydrocarbon nuclear translocator; BCRP; breast cancer resistant protein; CAD; C-terminal activation domain; CAIX; carbonic anhydrase IX; CAV1; caveolin-1; ccRCC; clear cell renal cell carcinoma; CSC; cancer stem cells; DAG; diacylglycerol; DUSP
Keywords: CNTs; carbon nanotubes; SWCNTs; single-walled carbon nanotubes; MWCNTs; multi-walled carbon nanotubes; HUVEC; human umbilical vein endothelial cells; ECs; endothelial cells; PAs; plasminogen activators; tPA; tissue-plasminogen activator; uPA; urokinase-pl
Keywords: Breast cancer; Estrogen receptor; EGFR; Epithelial to mesenchymal transition; Matrix metalloproteinases; uPA; tPA; Invasion; Migration;
Keywords: uPA; urokinase-type plasminogen activator; uPAR; urokinase-type plasminogen activator receptor; TR-FIA; time-resolved fluorescence immunoassays; OS; overall survival; PS; performance status; HR; hazard ratio; BID; bis in die = twice daily; Urokinase pla
Keywords: BC; bladder cancer; NMI; nonmuscle invasive; MMP; matrix metalloproteinase; uPA; urokinase-type plasminogen activator; NO; nitric oxide; iNOS; inducible nitric oxide synthase; nNOS; neuronal nitric oxide synthase; eNOS; endothelial nitric oxide synthase;
Keywords: AR; androgen receptor; DMEM; Dulbecco's minimal essential medium; FCS; fetal calf serum; GR; glucocorticoid receptor; GRE; glucocorticoid response element; GST; glutathione S-transferase; HEK; human embryonic kidney; IPTG; isopropyl-β-d-thiogalactoside
Keywords: COX-2; cyclooxygenase-2; CTLs; Cytotoxic T Lymphocytes; DCs; dendritic cells; ECM; extracellular matrix; EGF; epidermal growth factor; FAK; focal adhesion kinase; FAP-α; fibroblast activation protein-α; FGF; fibroblast growth factor; HSCs; hepatic stell
Keywords: APC; adenomatous polyposis coli; APE1/Ref; apurinic apyrimidinic endonuclease redox effector factor; APK; activated protein kinase; BTG; B-cell translocation gene; CSC; cancer stem cells; CSF; colony-stimulating factor; DSH; disheveled; ECGF1; endothelial
Keywords: PAI-1; plasminogen activator inhibitor-1; uPA; urokinase; tPA; tissue plasminogen activator; NF-κB; nuclear factor kappa-B; LPS; lipopolysaccharide; TNF; tumor necrosis factor; IL-1; interleukin-1; IL-6; interleukin-6; TLR4; toll-like receptor 4; ERK; ex
Keywords: AMC; Airborne molecular contamination; UPA; Ultra-pure air; Immersing photochemical oxidation;
Keywords: Hepatocyte; Liver; Chimera; Humanization; Animal Model; AFC8; FKBP-Caspase 8 gene driven by the albumin promoter; CYP; cytochrome; Fah; fumarylacetoacetate hydrolase; FRG; Fah/Rag2/interleukin common gamma chain knockout; NOD; non-obese diabetic; NTBC; 2-
A novel solution phase PAI-1/uPA-biotin complex assay for the measurement of active PAI-1 in plasma
Keywords: PAI-1; Plasminogen Activator Inhibitor 1; uPA; urokinase-type plasminogen activator; mAb; Monoclonal Antibody; pAb; Polyclonal Antibody; PE; Streptavidin-R-Phycoerythrin;
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Keywords: HCV; Glecaprevir; Pibrentasvir; Sofosbuvir; NS5A inhibitor resistance associated variant; P32 deletion; Human hepatocyte chimeric mouse; ASV; asunaprevir; DAAs; Direct-acting antivirals; DCV; daclatasvir; GLE; glecaprevir; HCV; hepatitis C virus; LDV; led
Two B-cell epitope vaccines based on uPA effectively inhibit fertility in male mice
Keywords: Immunocontraception; uPA; B-cell epitope vaccine;
Schistosoma mansoni venom allergen-like protein 18 (SmVAL18) is a plasminogen-binding protein secreted during the early stages of mammalian-host infection
Keywords: SmVAL; Schistosoma mansoni venom allergen-like; SCP/TAPS; sperm coat protein/Tpx-1/Ag5/PR-1/Sc7; ECM; extracellular matrix; BM; basement membrane; PLG; plasminogen; uPA; urokinase-type plasminogen activator; Schistosomiasis; SCP/TAPS; SmVAL18; Plasminogen
Scutellaria: Debates on the anticancer property
Keywords: Bcl-2; B-cell lymphoma 2; 5-FU; 5-Fluorouracil; TGF-β1; transforming growth factor beta 1; PTEN; phosphatase and tensin homolog; HIF-1α; hypoxia-inducible factor 1-alpha; MAPK; mitogen-activated protein kinase; CRC; cyclic redundancy check; SHH; sonic h
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
Keywords: 15-LOX-1; 15-lipoxygenase; AIF; apoptosis inducing factor; APC; adenomatous polyposis coli; AKT or PKB; protein kinase B; ATG16L2; autophagy related 16 like 2; AUC; area under the curve; Bad; Bcl-2 associated death promoter; Bcl-2; B-cell lymphoma 2; Bcl-
Model for Hormonal Emergency Contraception (HEC) in cycling and mated guinea pigs - Studies with the Progesterone Receptor Modulators (PRM) Ulipristal Acetate (UPA/CDB2914) and EC317
Keywords: CI; confidence interva); CL; corpus luteum; EIA; enzyme immunoassay; HEC; hormonal emergency contraception; LNG; levonorgestrel; P; progesterone; PGF2α; prostaglandin F2α; s.c.; subcutaneous; UPA; ulipristal acetate, CDB2914; PRM; progesterone receptor
Improving the catalytic efficiency of Fibrinolytic enzyme from Serratia marcescens subsp. sakuensis by chemical modification
Keywords: CAD; coronary artery disease; VTE; venous thromboembolism; tPA; tissue-type plasminogen activator; uPA; urokinase-type plasminogen activator; SK; streptokinase; DEPC; Diethylpyrocarbonate; DTNB; 5, 5-Dithio-bis-(2-nitrobenzoic) acid; EDAC; 1-Ethyl-3-(3-di
Integrin αvβ6: Structure, function and role in health and disease
Keywords: DC; dendritic cells; EBV; Epstein-Barr virus; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; EMT; epithelial-to-mesenchymal transformation; ERK; extracellular signal-regulated kinase; FMDV; foot-and-mouth disease virus; HSV; herpes s